KBIO LABS Inc. (KOSDAQ:038530)
South Korea · Delayed Price · Currency is KRW 999.00
+39.00 (4.06%)
At close: Aug 26, 2026
KBIO LABS Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 92,082 | 87,312 | 76,514 | 27,325 | 31,129 | 8,722 |
Revenue Growth | 57.60% | 14.11% | 180.02% | -12.22% | 256.89% | 52.80% |
Gross Profit Gross Profit Growth | 13,314 | 12,517 | 11,660 | 3,595 | 3,671 | 1,899 |
Operating Income Operating Income Growth | 1,416 | 755.63 | -1,110 | -616.78 | 453.41 | -5,087 |
Net Income Net Income Growth | -14,883 | -3,200 | -6,791 | -12,674 | -7,665 | -19,466 |
Earnings Per Share EPS Growth | -645.34 | -140.00 | -295.00 | -621.94 | -421.16 | -1261.50 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
ICT Business Division ICT Business Division Growth | 50,821 | 49,118 | - | - | - |
Bio Distribution Division Bio Distribution Division Growth | 36,491 | 27,397 | 27,325 | 31,119 | 4,806 |
Total Total Growth | 87,312 | 76,514 | 27,325 | 31,129 | 8,722 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 15,084 | 65,434 | 52,481 | 56,587 | 45,132 | 57,240 |
Total Debt Total Debt Growth | 298.03 | 585.81 | 754.97 | 3,187 | 10,563 | 19,766 |
Net Cash (Debt) Net Cash Growth | 14,786 | 64,848 | 51,726 | 53,399 | 34,569 | 37,474 |
Net Cash Growth | -71.40% | 25.37% | -3.13% | 54.47% | -7.75% | 2156.68% |
Net Cash Per Share Net Cash Per Share Growth | 639.67 | 2807.36 | 2239.29 | 2612.81 | 1899.36 | 2425.66 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 5,261 | 8,196 | -119.17 | -1,463 | 3,784 | -1,120 |
Capital Expenditures CapEx Growth | -25.02 | -35.84 | -71.16 | -7.95 | -15.63 | -93.37 |
Free Cash Flow Free Cash Flow Growth | 5,236 | 8,160 | -190.34 | -1,471 | 3,768 | -1,213 |
Free Cash Flow Growth | -20.96% | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 14.46% | 14.34% | 15.24% | 13.16% | 11.79% | 21.77% |
Operating Margin | 1.54% | 0.86% | -1.45% | -2.26% | 1.46% | -58.33% |
Pretax Margin | -3.58% | -5.59% | -12.89% | -43.25% | -22.53% | -190.15% |
Profit Margin | -16.16% | -3.67% | -8.88% | -46.38% | -24.62% | -223.18% |
FCF Margin | 5.69% | 9.35% | -0.25% | -5.38% | 12.11% | -13.91% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
P/FCF Ratio | 4.93 | 3.41 | - | - | 9.79 | - |
PS Ratio | 0.28 | 0.32 | 0.33 | 1.19 | 1.19 | 12.31 |